Thomas Leist, MD

Contact Dr. Leist

900 Walnut Street
Ste. 200
Philadelphia, PA 19107

(215) 955-6871
(215) 503-2990 (fax)

Medical School
University of Miami School of Medicine - 1993

Residency
Cornell Medical Center - New York Hospital

Fellowship
National Institute of Health

Board Certification
Neurology

Hospital Appointment
Thomas Jefferson University Hospital

University Appointment
Associate Professor

Publications

Most recent Peer-reviewed Publications

1. Cladribine: Mode of action and implications for treatment of multiple sclerosis
2. Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics
3. Human optic nerve DTI with EPI geometric distortion correction
4. Thickness of retinal nerve fiber layer correlates with disease duration in parallel with corticospinal tract dysfunction in untreated multiple sclerosis
5. Toward a practical protocol for human optic nerve DTI with EPI geometric distortion correction
6. Phase Labeling Using Sensitivity encoding (PLUS): Data acquisition and image reconstruction for geometric distortion correction in EPI
7. When metals compete: A case of copper-deficiency myeloneuropathy and anemia
8. Geometric distortion correction in EPI by phase labeling using sensitivity encoding (PLUS)
9. Multiple sclerosis risk after optic neuritis: Final optic neuritis treatment trial follow-up
10. A phase I trial of interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis (Current Medical Research and Opinion (2006) 22, 9, (1671-1678) DOI: 10.1185/030079906X120931)
11. The potential role for cladribine in the treatment of multiple sclerosis: Clinical experience and development of an oral tablet formulation
12. Commentary I: Pathophysiologic construct for neuronal degeneration/ regeneration in multiple sclerosis
13. Commentary II: Clinical aspects of assessing neuronal health in multiple sclerosis
14. MSBase: An international, online registry and platform for collaborative outcomes research in multiple sclerosis
15. A phase I trial of an interleukin-12/23 monoclonal antibody in relapsing multiple sclerosis
16. Progressive necrotizing myelopathy: Part of the spectrum of neuromyelitis optica?
17. Clinical-magnetic resonance imaging correlations in multiple sclerosis
18. A randomized, multicentre, open-label, parallel-group trial of the tolerability of interferon beta-1a (Rebif®) administered by autoinjection or manual injection in relapsing-remitting multiple sclerosis
19. Iriterferon-β1a therapy in human T-lymphotropic virus type I-associated neurologic disease
20. Involvement of β-chemokines in the development of inflammatory demyelination

View All Publications